Jefferies Maintains Buy on Eli Lilly and Co, Raises Price Target to $1015
Portfolio Pulse from Benzinga Newsdesk
Jefferies analyst Akash Tewari maintains a Buy rating on Eli Lilly and Co (NYSE:LLY) and raises the price target from $994 to $1015.
June 24, 2024 | 6:24 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Jefferies analyst Akash Tewari maintains a Buy rating on Eli Lilly and Co (NYSE:LLY) and raises the price target from $994 to $1015.
The raised price target and maintained Buy rating from Jefferies is a positive signal for investors, indicating confidence in Eli Lilly's future performance. This is likely to have a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100